LOFEXIDINE | LOFEXIDINE | ATC N07BC04
NERVOUS SYSTEM CENTRAL ALPHA-2 ADRENERGIC AGONIST INDICATED FOR MITIGATION OF OPIOID WITHDRAWAL SYMPTOMS TO FACILITATE ABRUPT OPIOID DISCONTINUATION IN ADULTS | ORAL | Cmax 3.16 NANOMOLAR Tmax 4 HOUR F 72 PERCENT (0.36 MILLIGRAM) VD 480 LITER PPB 55 PERCENT Cl 17.6 LITER / HOUR HT 12 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | ALPHA-2 ADRENERGIC RECEPTOR | GPCR ADA2A_HUMAN AGONIST P08913 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |